Crystalline of N-[4-[2-(2-Amino-4,7-dihydro-4oxo-3H-pyrrolo[2,3-D]pyrimidin-5-YL)ethyl]benzoyl]-L-glutamic acid and process therefor

Crystalline of N-[4-[2-(2-Amino-4,7-dihydro-4oxo-3H-pyrrolo[2,3-D]pyrimidin-5-YL)ethyl]benzoyl]-L-glutamic acid and process therefor

The invention relates to the field of pharmaceutical and organic chemistry and provides an improved process for preparing the novel heptahydrate crystalline salt of multitargeted antifolate N-[4-[2-(2-amino-4,7-dihydro-4-oxo-3H-pyrrolo[2,3-d]-pyrimidin-5-yl)ethyl]benzoyl]-L-glutamic acid.

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Chelius, Erik Christopher, Reutzel-Edens, Susan Marie, Van den Berghe Snorek, Sharon
Format: Patent
Sprache:eng
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator Chelius, Erik Christopher
Reutzel-Edens, Susan Marie
Van den Berghe Snorek, Sharon
description The invention relates to the field of pharmaceutical and organic chemistry and provides an improved process for preparing the novel heptahydrate crystalline salt of multitargeted antifolate N-[4-[2-(2-amino-4,7-dihydro-4-oxo-3H-pyrrolo[2,3-d]-pyrimidin-5-yl)ethyl]benzoyl]-L-glutamic acid.
format Patent
fullrecord <record><control><sourceid>uspatents_EFH</sourceid><recordid>TN_cdi_uspatents_grants_07138521</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>07138521</sourcerecordid><originalsourceid>FETCH-uspatents_grants_071385213</originalsourceid><addsrcrecordid>eNqNykELgjAYxnEvHaL6DjsW-EJOxa5hhQfp1CUkYrmpg7lXtgmtcx88gz5Ap9__gWcevHPjrWNKSS0INuQMVQIVhTWFfS81QhJmwGXnuZkanwhxAYM3BhVWNIzhcJuW7CWXGlK4lhvhOq9uD6FfOAkltGp0rJc1YbXkhGlOBoO1sJa4ThjRoFkGs4YpK1Y_FwE5HS95AaMdmBPa2Xtr2JdtFsW7lEbxH5cPtJJITg</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Crystalline of N-[4-[2-(2-Amino-4,7-dihydro-4oxo-3H-pyrrolo[2,3-D]pyrimidin-5-YL)ethyl]benzoyl]-L-glutamic acid and process therefor</title><source>USPTO Issued Patents</source><creator>Chelius, Erik Christopher ; Reutzel-Edens, Susan Marie ; Van den Berghe Snorek, Sharon</creator><creatorcontrib>Chelius, Erik Christopher ; Reutzel-Edens, Susan Marie ; Van den Berghe Snorek, Sharon ; Eli Lilly and Company</creatorcontrib><description>The invention relates to the field of pharmaceutical and organic chemistry and provides an improved process for preparing the novel heptahydrate crystalline salt of multitargeted antifolate N-[4-[2-(2-amino-4,7-dihydro-4-oxo-3H-pyrrolo[2,3-d]-pyrimidin-5-yl)ethyl]benzoyl]-L-glutamic acid.</description><language>eng</language><creationdate>2006</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://image-ppubs.uspto.gov/dirsearch-public/print/downloadPdf/7138521$$EPDF$$P50$$Guspatents$$Hfree_for_read</linktopdf><link.rule.ids>230,308,780,802,885,64039</link.rule.ids><linktorsrc>$$Uhttps://image-ppubs.uspto.gov/dirsearch-public/print/downloadPdf/7138521$$EView_record_in_USPTO$$FView_record_in_$$GUSPTO$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>Chelius, Erik Christopher</creatorcontrib><creatorcontrib>Reutzel-Edens, Susan Marie</creatorcontrib><creatorcontrib>Van den Berghe Snorek, Sharon</creatorcontrib><creatorcontrib>Eli Lilly and Company</creatorcontrib><title>Crystalline of N-[4-[2-(2-Amino-4,7-dihydro-4oxo-3H-pyrrolo[2,3-D]pyrimidin-5-YL)ethyl]benzoyl]-L-glutamic acid and process therefor</title><description>The invention relates to the field of pharmaceutical and organic chemistry and provides an improved process for preparing the novel heptahydrate crystalline salt of multitargeted antifolate N-[4-[2-(2-amino-4,7-dihydro-4-oxo-3H-pyrrolo[2,3-d]-pyrimidin-5-yl)ethyl]benzoyl]-L-glutamic acid.</description><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2006</creationdate><recordtype>patent</recordtype><sourceid>EFH</sourceid><recordid>eNqNykELgjAYxnEvHaL6DjsW-EJOxa5hhQfp1CUkYrmpg7lXtgmtcx88gz5Ap9__gWcevHPjrWNKSS0INuQMVQIVhTWFfS81QhJmwGXnuZkanwhxAYM3BhVWNIzhcJuW7CWXGlK4lhvhOq9uD6FfOAkltGp0rJc1YbXkhGlOBoO1sJa4ThjRoFkGs4YpK1Y_FwE5HS95AaMdmBPa2Xtr2JdtFsW7lEbxH5cPtJJITg</recordid><startdate>20061121</startdate><enddate>20061121</enddate><creator>Chelius, Erik Christopher</creator><creator>Reutzel-Edens, Susan Marie</creator><creator>Van den Berghe Snorek, Sharon</creator><scope>EFH</scope></search><sort><creationdate>20061121</creationdate><title>Crystalline of N-[4-[2-(2-Amino-4,7-dihydro-4oxo-3H-pyrrolo[2,3-D]pyrimidin-5-YL)ethyl]benzoyl]-L-glutamic acid and process therefor</title><author>Chelius, Erik Christopher ; Reutzel-Edens, Susan Marie ; Van den Berghe Snorek, Sharon</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-uspatents_grants_071385213</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2006</creationdate><toplevel>online_resources</toplevel><creatorcontrib>Chelius, Erik Christopher</creatorcontrib><creatorcontrib>Reutzel-Edens, Susan Marie</creatorcontrib><creatorcontrib>Van den Berghe Snorek, Sharon</creatorcontrib><creatorcontrib>Eli Lilly and Company</creatorcontrib><collection>USPTO Issued Patents</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>Chelius, Erik Christopher</au><au>Reutzel-Edens, Susan Marie</au><au>Van den Berghe Snorek, Sharon</au><aucorp>Eli Lilly and Company</aucorp><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Crystalline of N-[4-[2-(2-Amino-4,7-dihydro-4oxo-3H-pyrrolo[2,3-D]pyrimidin-5-YL)ethyl]benzoyl]-L-glutamic acid and process therefor</title><date>2006-11-21</date><risdate>2006</risdate><abstract>The invention relates to the field of pharmaceutical and organic chemistry and provides an improved process for preparing the novel heptahydrate crystalline salt of multitargeted antifolate N-[4-[2-(2-amino-4,7-dihydro-4-oxo-3H-pyrrolo[2,3-d]-pyrimidin-5-yl)ethyl]benzoyl]-L-glutamic acid.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng
recordid cdi_uspatents_grants_07138521
source USPTO Issued Patents
title Crystalline of N-[4-[2-(2-Amino-4,7-dihydro-4oxo-3H-pyrrolo[2,3-D]pyrimidin-5-YL)ethyl]benzoyl]-L-glutamic acid and process therefor
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-26T09%3A04%3A38IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-uspatents_EFH&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=Chelius,%20Erik%20Christopher&rft.aucorp=Eli%20Lilly%20and%20Company&rft.date=2006-11-21&rft_id=info:doi/&rft_dat=%3Cuspatents_EFH%3E07138521%3C/uspatents_EFH%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true